Search

In Stock

Buy Jyseleca (filgotinib) Online

DISEASE INDICATIONS: Rheumatoid Arthritis

MANUFACTURER: Galapagos

USAGE: Oral

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Pharmaceuticals and Medical Devices Agency (PMDA)

 

Jyseleca is a pharmaceutical medication that contains the active ingredient filgotinib. It belongs to a class of medications known as Janus kinase (JAK) inhibitors and is primarily used in the treatment of various autoimmune diseases, including rheumatoid arthritis. Filgotinib works by targeting specific enzymes involved in the inflammatory process, helping to reduce inflammation and manage the symptoms of these conditions.

From $1,239.61

Clear
Compare

Jyseleca is a pharmaceutical medication that contains the active ingredient filgotinib. It belongs to a class of medications known as Janus kinase (JAK) inhibitors and is primarily used in the treatment of various autoimmune diseases, including rheumatoid arthritis. Filgotinib works by targeting specific enzymes involved in the inflammatory process, helping to reduce inflammation and manage the symptoms of these conditions.

Here is a detailed description of Jyseleca:

Active Ingredient:

  • Filgotinib: Filgotinib is a selective Janus kinase 1 (JAK1) inhibitor. It works by inhibiting the activity of JAK1, which is involved in the signaling pathways that contribute to inflammation. By doing so, filgotinib helps reduce the inflammatory response in autoimmune diseases.

Indications:

Jyseleca is indicated for the treatment of the following medical conditions:

  1. Rheumatoid Arthritis (RA): Jyseleca is used in combination with methotrexate to treat moderate to severe rheumatoid arthritis in adult patients who have not adequately responded to other disease-modifying antirheumatic drugs (DMARDs).
  2. Psoriatic Arthritis: It is also used to treat psoriatic arthritis, a type of inflammatory arthritis that occurs in some individuals with psoriasis.
  3. Ankylosing Spondylitis: Jyseleca is indicated for the treatment of ankylosing spondylitis, a chronic inflammatory disease that primarily affects the spine.

Usage:

The dosing and administration of Jyseleca are determined by a healthcare provider and depend on the specific condition being treated. It is typically taken orally in the form of tablets, usually once daily.

Mechanism of Action:

Filgotinib, the active ingredient in Jyseleca, works by selectively inhibiting JAK1, a key enzyme in the inflammatory signaling pathways. By doing so, it interferes with the inflammatory response, helping to reduce pain, swelling, and joint damage in autoimmune diseases.

Benefits:

Jyseleca offers the benefit of effectively managing autoimmune diseases, particularly rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. It can help reduce inflammation, alleviate symptoms, and improve the overall quality of life for patients.

Precautions:

Before starting Jyseleca, patients should undergo a thorough evaluation by a healthcare provider. It is important to inform the healthcare provider of any allergies, medical conditions, or other medications being taken, as these factors can affect the safety and efficacy of the medication.

Side Effects:

Common side effects of Jyseleca may include upper respiratory tract infections, headache, and increased liver enzyme levels. Patients may also be at a slightly increased risk of infections while taking Jyseleca. Patients should discuss any side effects or concerns with their healthcare provider.

In conclusion, Jyseleca (filgotinib) is a medication used to treat autoimmune diseases, including rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. It works by selectively inhibiting the JAK1 enzyme to reduce inflammation and improve symptoms. Patients should use it as directed by their healthcare provider and be aware of potential side effects and precautions associated with its use.

Package

30 tablets of 100 mg, 30 tablets of 200 mg

Reviews

There are no reviews yet.

Write a review

Your email address will not be published. Required fields are marked *

Bestsellers

Buy Jyseleca (filgotinib) Online

From $1,239.61
(0 Reviews)
DISEASE INDICATIONS: Rheumatoid Arthritis MANUFACTURER: Galapagos USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Pharmaceuticals and Medical Devices Agency (PMDA)   Jyseleca is a pharmaceutical medication that contains the active ingredient filgotinib. It belongs to a class of medications known as Janus kinase (JAK) inhibitors and is primarily used in the treatment of various autoimmune diseases, including rheumatoid arthritis. Filgotinib works by targeting specific enzymes involved in the inflammatory process, helping to reduce inflammation and manage the symptoms of these conditions.

Buy Xeljanz : Tofacitinib 5 mg Tablets Online

$417.52
(0 Reviews)
Brand Name: Xeljanz Composition: Tofacitinib Manufactured by: Pfizer Pharmaceuticals, Inc. Strength: 5 mg Form: Tablets Packing: Pack of 60 Tablets Prescription Required *

Buy Stelara (ustekinumab) Injection Online

From $5,034.51
(0 Reviews)
Stelara, known by its generic name Ustekinumab, is a prescription medication used in the treatment of certain autoimmune diseases, primarily plaque psoriasis, psoriatic arthritis, and Crohn's disease.

Buy Skyrizi (Risankizumab) Online

From $14,517.47
(0 Reviews)
DISEASE INDICATIONS: Psoriasis MANUFACTURER: AbbVie Ltd USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Therapeutic Goods Administration (TGA) Skyrizi (risankizumab) is a prescription medication used to treat moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. It is a monoclonal antibody that works by blocking the interleukin-23 (IL-23) pathway, which is involved in the development and progression of psoriasis.

Buy Tremfya (guselkumab) Online

$2,860.64
(0 Reviews)
DISEASE INDICATIONS: Psoriasis MANUFACTURER: Janssen Biotech USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Health Canada Pharmaceuticals and Medical Devices Agency (PMDA) Therapeutic Goods Administration (TGA) Tremfya is a pharmaceutical medication that contains the active ingredient guselkumab. It belongs to a class of medications known as interleukin-23 (IL-23) inhibitors and is primarily used in the treatment of certain chronic skin conditions, particularly moderate to severe plaque psoriasis. Guselkumab works by targeting specific proteins in the immune system that play a role in the development of psoriatic skin lesions, thereby reducing the symptoms associated with this condition.

Buy Rinvoq (upadacitinib) Online

$1,955.31
(0 Reviews)
Rinvoq is a pharmaceutical medication that contains the active ingredient upadacitinib. It belongs to a class of medications known as Janus kinase (JAK) inhibitors and is primarily used to treat autoimmune diseases, particularly rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Upadacitinib works by targeting specific enzymes in the immune system, helping to reduce inflammation and alleviate the symptoms associated with these conditions.

Buy Taltz (ixekizumab) Online

From $2,499.58
(0 Reviews)
DISEASE INDICATIONS: Psoriasis MANUFACTURER: Eli Lilly Nederland B.V. USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Health Canada Therapeutic Goods Administration (TGA) Taltz (ixekizumab) is a prescription medication used to treat moderate to severe plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis in adults. It is a monoclonal antibody that works by blocking interleukin 17A (IL-17A), a cytokine that plays a key role in the development and progression of these inflammatory diseases.

Back to Top
Product has been added to your cart